Chronic Heart Disease. Chronic Ischaemic Heart Disease, unspecified / Heart Failure, unspecified
Conditions
Interventions
Intervention 1: Experimental group: After obtaining permission from the Research Ethics Committee of Sabzevar University of Medical Sciences and informed consent of patients entering the study, patien
Behavior
Experimental group: After obtaining permission from the Research Ethics Committee of Sabzevar University of Medical Sciences and informed consent of patients entering the study, patients were randomly
Control group:
After obtaining permission from the Research Ethics Committee of Sabzevar University of Medical Sciences and informed consent of patients entering the study, patients were randomly all
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Confirmed diagnosis of Heart Failure or Myocardial Infarction; Age 30 to 60 years; Not any psychiatric disorder; Not any chronic disease; Not using sedatives drug. Exclusion criteria: Reluctance to continue participating in the exercises; Presence of crisis or disaster during the intervention period; Death, Use of sedatives drug.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of sleep in patients with Chronic Heart Disease. Timepoint: Before the intervention and one month after intervention. Method of measurement: Pittsburgh Sleep Quality Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Morteza Hashemi Nik
Sabzevar University of Medical Sciences
Outcome results
None listed